<?xml version="1.0"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="en">
	<id>http://mfrdinfo.com/ems1/index.php?action=history&amp;feed=atom&amp;title=Pepcid</id>
	<title>Pepcid - Revision history</title>
	<link rel="self" type="application/atom+xml" href="http://mfrdinfo.com/ems1/index.php?action=history&amp;feed=atom&amp;title=Pepcid"/>
	<link rel="alternate" type="text/html" href="http://mfrdinfo.com/ems1/index.php?title=Pepcid&amp;action=history"/>
	<updated>2026-06-21T15:14:25Z</updated>
	<subtitle>Revision history for this page on the wiki</subtitle>
	<generator>MediaWiki 1.32.0</generator>
	<entry>
		<id>http://mfrdinfo.com/ems1/index.php?title=Pepcid&amp;diff=27680&amp;oldid=prev</id>
		<title>Mfrdmanager: Created page with &quot;==Section 8 - MEDICATION GUIDELINES== ===ANTIHISTAMINES===  ====Famotidine (PEPCID) / H2 Histamine blocker==== '''DESCRIPTION''' * Famotidine inhibits histamine at H2 receptor...&quot;</title>
		<link rel="alternate" type="text/html" href="http://mfrdinfo.com/ems1/index.php?title=Pepcid&amp;diff=27680&amp;oldid=prev"/>
		<updated>2020-11-12T19:37:37Z</updated>

		<summary type="html">&lt;p&gt;Created page with &amp;quot;==Section 8 - MEDICATION GUIDELINES== ===ANTIHISTAMINES===  ====Famotidine (PEPCID) / H2 Histamine blocker==== &amp;#039;&amp;#039;&amp;#039;DESCRIPTION&amp;#039;&amp;#039;&amp;#039; * Famotidine inhibits histamine at H2 receptor...&amp;quot;&lt;/p&gt;
&lt;p&gt;&lt;b&gt;New page&lt;/b&gt;&lt;/p&gt;&lt;div&gt;==Section 8 - MEDICATION GUIDELINES==&lt;br /&gt;
===ANTIHISTAMINES===&lt;br /&gt;
&lt;br /&gt;
====Famotidine (PEPCID) / H2 Histamine blocker====&lt;br /&gt;
'''DESCRIPTION'''&lt;br /&gt;
* Famotidine inhibits histamine at H2 receptor site in the gastric parietal cell, which inhibits gastric acid secretion.&lt;br /&gt;
'''INDICATIONS'''&lt;br /&gt;
* [[Allergic Reaction Anaphylactic Shock|Hives; Allergic reaction]]; Short term treatment of duodenal and gastric ulcers, management of GERD and erosive esophagitis.&lt;br /&gt;
'''CONTRAINDICATIONS'''&lt;br /&gt;
* Hypersensitivity to the medication&lt;br /&gt;
* Renal impairment&lt;br /&gt;
'''PRECAUTIONS'''&lt;br /&gt;
* Hepatic disease, renal disease, elderly&lt;br /&gt;
'''DOSAGE'''&lt;br /&gt;
* Currently supplied in 20mg/50 ml&lt;br /&gt;
* Adults: 20mg/ 50ml given at a wide open rate. &lt;br /&gt;
* Pediatrics- refer to the Handtevy System.&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
[[Category:Medication Guidelines|Pepcid]]&lt;/div&gt;</summary>
		<author><name>Mfrdmanager</name></author>
		
	</entry>
</feed>